Cargando…

Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis

INTRODUCTION: Whole brain radiotherapy (WBRT) has been the mainstay treatment of brain metastases (BM) in non-small cell lung cancer (NSCLC) patients for years. Temozolomide (TMZ) could penetrate the blood–brain barrier and some studies showed that TMZ plus MBRT may improve clinical effectiveness. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Hua, Zheng, Shu-Yue, Zhou, Tian, Cui, Hui-Juan, Hu, Kai-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004645/ https://www.ncbi.nlm.nih.gov/pubmed/32000358 http://dx.doi.org/10.1097/MD.0000000000018455

Ejemplares similares

Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis
por: Shieh, Li-Tsun, et al.
Publicado: (2022)

Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review
por: Yang, Yi, et al.
Publicado: (2020)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018)

Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
por: Zhu, Ying, et al.
Publicado: (2018)

Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
por: Han, Jianguo, et al.
Publicado: (2021)

Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study
por: He, Jinlin, et al.
Publicado: (2021)

Re-irradiation of multiple brain metastases using CyberKnife stereotactic radiotherapy: Case report
por: Zhou, Han, et al.
Publicado: (2021)

Therapeutic effectiveness and safety of sequential ICIs with radiotherapy for symptomatic brain and bone metastases in NSCLC patients
por: Tang, Cuiping, et al.
Publicado: (2022)

Musashi1 expression is negatively correlated with numb expression in brain metastases
por: Dong, Yalan, et al.
Publicado: (2020)

Brain metastases from esophageal cancer: A case report
por: Qie, Shuai, et al.
Publicado: (2020)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

Brain metastases from esophageal cancer: A retrospective analysis of the outcome after surgical resection followed by radiotherapy
por: Stavrinou, Pantelis, et al.
Publicado: (2019)

Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
por: Huang, Zhangheng, et al.
Publicado: (2020)

Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report
por: Yan, Hongxia, et al.
Publicado: (2020)

A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

Evaluation of imaging findings and prognostic factors after whole-brain radiotherapy for carcinomatous meningitis from breast cancer: A retrospective analysis
por: Okada, Yukinori, et al.
Publicado: (2020)

Pemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases: A case report and literature review
por: He, Guangzhao, et al.
Publicado: (2016)

LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases: An Observational Study
por: Hu, Nan, et al.
Publicado: (2015)

Recurrent spinal primitive neuroectodermal tumor with brain and bone metastases: A case report
por: Chen, Frank, et al.
Publicado: (2017)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Radiotherapy plus EGFR TKIs in non‐small cell lung cancer patients with brain metastases: an update meta‐analysis
por: Jiang, Tao, et al.
Publicado: (2016)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

The impact of baseline brain metastases on clinical benefits and progression patterns after first-line crizotinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer
por: Chen, Yuqi, et al.
Publicado: (2021)

Successful treatment of 2 patients with brain metastases from non-small cell lung cancer with epidermal growth factor receptor mutation receiving dacomitinib: A case report
por: Zhao, Songchen, et al.
Publicado: (2021)

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Intensity-modulated radiation therapy for patients with 1 to 3 brain metastases in recursive partitioning analysis class 3
por: Yang, Jia, et al.
Publicado: (2017)

Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer
por: Zhou, Lin, et al.
Publicado: (2014)

Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update
por: Ming, Xin, et al.
Publicado: (2016)

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015)

Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis
por: Qin, Hong, et al.
Publicado: (2014)

The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases
por: Deng, Xia, et al.
Publicado: (2017)

The usefulness of stereotactic radiosurgery for recursive partitioning analysis class II/III lung cancer patients with brain metastases in the modern treatment era
por: Ha, In Bong, et al.
Publicado: (2019)

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report
por: Zhang, Gairong, et al.
Publicado: (2021)

High-dose insulin and dexamethasone combined with radiotherapy in endometrial stromal sarcoma recurring with multiple metastases: A case report
por: Liang, Libin, et al.
Publicado: (2023)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023)

The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapy
por: Hannan, Enda J., et al.
Publicado: (2017)

Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report
por: Jin, Yonglong, et al.
Publicado: (2021)

Homologous platelet gel on radiation-induced dermatitis in a patient receiving head and neck radiotherapy plus cetuximab: A case report
por: Guberti, Monica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5m1hkr8vht2rmkos7a3vkuodcr